Asio Capital LLC Reduces Stake in IQVIA Holdings Inc.

Asio Capital LLC has significantly reduced its stake in IQVIA Holdings Inc. (NYSE:IQV) by 59.2% during the fourth quarter, as reported in its latest Form 13F filing to the Securities and Exchange Commission. Following this change, the fund currently holds 4,304 shares of IQVIA's stock after selling 6,233 shares throughout the quarter. At the end of the recent reporting period, Asio Capital LLC's investments in IQVIA were valued at $846,000.

In addition to Asio Capital's actions, other institutional investors have also been adjusting their positions in IQVIA. For instance, Capital Performance Advisors LLP acquired a new stake in the company worth about $27,000 during the third quarter. Similarly, Park Place Capital Corp purchased shares valued at approximately $28,000 in the same period. Avior Wealth Management LLC increased its holdings in IQVIA by 117.6% during the third quarter, now owning 161 shares with a total value of $38,000 after adding 87 shares over the last quarter.

Moreover, Assetmark Inc. expanded its stake in IQVIA by an impressive 612.5% in the third quarter, raising its holdings to 228 shares now worth $54,000 after the purchase of 196 additional shares. Furthermore, UMB Bank n.a. boosted its position by 74.4%, now holding 232 shares valued at $55,000 after acquiring 99 shares during the period. It's worth noting that institutional investors currently own 89.62% of IQVIA's stock.

IQVIA Stock Performance

On Friday, shares of IQVIA opened at $204.54. The company has a 50-day simple moving average of $199.71 and a 200-day simple moving average of $221.06. IQVIA Holdings Inc. has experienced a 52-week low of $187.62 and a high of $261.73. The company's market capitalization stands at $37.12 billion, with a price-to-earnings (P/E) ratio of 26.84, a price/earnings to growth (P/E/G) ratio of 2.14, and a beta of 1.48. Its debt-to-equity ratio is reported at 1.76, alongside quick and current ratios both at 0.81.

Broker Ratings on IQVIA

Several financial brokerages have recently provided their insights on IQVIA. For example, Leerink Partners reaffirmed an "outperform" rating but reduced its price target from $260.00 to $248.00 in a research note issued on November 19th. Also, StockNews.com downgraded IQVIA's rating from "buy" to "hold" on November 28th. Deutsche Bank Aktiengesellschaft reduced its price target from $270.00 to $265.00 while maintaining a "buy" rating on November 1st. The Goldman Sachs Group adjusted its target price from $280.00 to $250.00, also categorizing it as a "buy." Lastly, Barclays lowered its price objective from $260.00 to $255.00 while retaining an "overweight" rating on November 1st. Currently, investment analysts have issued four hold ratings, seventeen buy ratings, and one strong buy rating for the stock. MarketBeat data indicates that IQVIA holds an average rating of "Moderate Buy" with an average price target of $255.71.

Learn More About IQVIA

About IQVIA

IQVIA Holdings Inc. specializes in offering advanced analytics, technology solutions, and clinical research services to the life sciences sector across the Americas, Europe, Africa, and the Asia-Pacific regions. The company's operations are structured into three main segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.

Conclusion

As market conditions evolve, shifts in institutional ownership like those seen with Asio Capital LLC could have future implications for IQVIA Holdings Inc. Investors should continue to monitor performance trends and analyst ratings for insights on potential investment strategies.

Asio, Investment, IQVIA